Intellectual Property

DermTech has developed a broad, comprehensive, worldwide intellectual property portfolio, in addition to an umbrella patent that covers the use of any adhesive to obtain and analyze RNA in humans or animals, for any purpose. Patents have been filed for specific gene classifiers that distinguish a variety of dermatologic conditions, including classifiers that identify expression consistent with melanoma.